Clinical Nuclear Medicine

Skip Navigation LinksHome > February 2013 - Volume 38 - Issue 2 > Bone Metastases from Prostate Cancer: 18F-Fluoride PET/CT in...
Clinical Nuclear Medicine:
doi: 10.1097/RLU.0b013e31827a20d3
Interesting Images

Bone Metastases from Prostate Cancer: 18F-Fluoride PET/CT in a Patient With Discordant Bone Scintigraphy and 11C-Choline PET/CT

Garcia, Garzon Jr MD; Riera, Eduard MD; Valls, Eulalia MD; Soler, Marina MD; Bassa, Pere MD; Moragas, Merce MD; Lomeña, Francisco MD

Collapse Box


Abstract: Bone scintigraphy has been used extensively in prostate cancer patients to detect bone involvement.

11C-choline PET/CT is indicated when a biochemical recurrence is suspected, as this procedure is able to detect local recurrence, lymph-node infiltration, and metastases.

In cases where the results of these 2 procedures do not coincide, MRI is then usually performed. 18F-fluoride may become an alternative to MRI for bone imaging.

In our patient series, all bone lesions with 11C-choline uptake were metastases. 18F-Fluoride did not increase specificity of 11C-choline but increased sensitivity of bone scintigraphy. CT helped in the interpretation of osteoarthritis and trauma lesions.

© 2013 Lippincott Williams & Wilkins, Inc.


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.